The Technical Analyst
Select Language :
Addex Therapeutics Ltd [ADXN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Addex Therapeutics Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals

Addex Therapeutics Ltd is listed at the  Exchange

-2.23% $12.25

America/New_York / 28 mar 2024 @ 10:31


Addex Therapeutics Ltd: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 18.36 mill
EPS: -20.01
P/E: -0.610
Earnings Date: Mar 25, 2024
SharesOutstanding: 1.499 mill
Avg Daily Volume: 0.0095 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.610 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.10x
Company: PE -0.610 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.0744
(-99.39%) $-12.18
Date: 2024-03-28
Expected Trading Range (DAY)

$ 11.34 - 13.16

( +/- 7.44%)
ATR Model: 14 days

Forecast: 14:28 - $12.54

Live Trading Signals (every 1 min)

Forecast 1: 12:58 - $12.63
Forecast 2: 13:48 - $12.54
Forecast 3: 14:28 - $12.54
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price $12.25 (-2.23% )
Volume 0.0030 mill
Avg. Vol. 0.0095 mill
% of Avg. Vol 31.93 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Addex Therapeutics Ltd

Last 12 Months

Last 12 months chart data with high, low, open and close for Addex Therapeutics Ltd

RSI

Last 10 Buy & Sell Signals For ADXN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot–Marie–Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Last 10 Buy Signals

Date Signal @
GILDMar 28 - 14:31$73.43
EGXUSDMar 28 - 14:28200.37
DESOUSDMar 28 - 14:2930.87
FLIPUSDMar 28 - 14:295.23
BAKEUSDMar 28 - 14:29$0.449
BSVUSDMar 28 - 14:30$92.41
LUNRMar 28 - 14:286.11
LTCUSDMar 28 - 14:27$94.89
DIGGUSDMar 28 - 14:24895.32
CHRWMar 28 - 14:25$75.89

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.